Transplant Infectious Disease

Article	Citations
	95
	53
Utility of microbiologic testing in surveillance bronchoscopy following lung transplantation: A retrospective cohort study	53
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?	53
	48
Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis	41
Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study	39
Research Advice for Early Career Transplant Infectious Disease Clinicians	35
Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient	33
Atypical pneumonia testing in transplant recipients	31
Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom	29
Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients	29
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant	27
Short‐term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors	27
Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient	27
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review	25
Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review	25
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior tre	25
1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients	23
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient	23
Cytomegalovirus‐associated pseudomembranous colitis in a kidney transplant recipient	21
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin	21
Neuroinvasive West Nile virus infection in solid organ transplant recipients	21
Vaccine protection and how we measure it	21
Pathogen‐agnostic immune biomarkers that predict infection after solid organ transplantation	20

The Journal in 2024: Reflections and Thanks for Our Reviewers	20
The outcomes of Clostridioides difficile infection in inpatient liver transplant population	19
Cytomegalovirus‐Induced Arterial Intimal Fibrosis in the Kidney Transplant	19
Metagenomics in infectious disease diagnostics: Toward best‐use practices to optimize actionable results	19
Breakthrough COVID‐19 after SARS‐CoV‐2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy	19
A glimpse into my journey: Lung transplantation for COVID‐19	19
Could cell‐free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?	19
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research	19
Cover Image	18
Evaluation of Titer‐Proven Response Rates of Pediatric Hepatitis B‐Combination Vaccines in Adult Hematopoietic Cell Transplant Recipients	18
Surveillance for donor‐derived infections in Australia	17
Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective	17
Ultrasound for management of left ventricular assist device driveline infections: A single‐center experience	17
Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients	17
Into the unknown: Diagnosing mysterious brain lesions	16
Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study	16
Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program	16
Perspectives on donor‐derived infections from the Notify Library	16
Antifungal stewardship in solid‐organ transplantation: What is needed?	16
Impact of machine perfusion on transplant infectious diseases: New challenges and opportunities	16
The American Association of Tissue Banks tissue donor screening for Mycobacterium tuberculosis—Recommended criteria and literature review	15
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin	15
Role of cytomegalovirus specific cell‐mediated immunity in the monitoring of cytomegalovirus infection among living donor liver transplantation adult recipients: A single‐center experience	15
ChatGPT may help in counseling on strategies for safe living following solid organ transplantation	15
Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans	15
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients	15
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases	15
Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care	14
Donor‐derived infections: The Swiss perspective	14
Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients	14
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Di	14
Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real‐life data from a multicentre retrospective study	13
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis	13
Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients	13
Shorter is better: The case for short antibiotic courses for common infections in solid organ transplant recipients	12
SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps	12
A case of tuberculosis mimicking lung cancer in a kidney transplant recipient	12
Kidney transplant from hepatitis C viremic donors into aviremic recipients and risk for post‐transplant BK and cytomegalovirus infection	12
Omicron breakthrough infection in a kidney‐transplant patient given pre‐exposition casirivimab and imdevimab monoclonal antibodies	12
Trichophyton onychomycosis and deep dermatophytosis in a post‐heart transplant patient	12
Organ transplant patients, COVID‐19, and neutralizing monoclonal antibodies: The glass is half full	12
The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center	11
Correction to “Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial”	11
Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians	11
Systematic fungal biomarker or polymerase chain reaction testing in lung transplant recipients: Retrospective analysis to optimize their use	11
Riders on the Storm	11
Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients	11
Surgical site infection due to Mycobacterium fortuitum in a lung transplant recipient	11
Cytomegalovirus‐driven early‐onset lymphocytosis in hematopoietic allogeneic transplant mimicking a T‐cell lymphoma progression	10
QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation	10

Use of HCV NAT+ donors: A patient's perspective	10
Paradoxical outcomes of gram‐negative bloodstream infection in solid organ transplant recipients	10
When you need to dive in the deep end—Transplanting SARS‐CoV‐2 PCR+ recipients	10
Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial	10
Bloodstream infections among intestinal and multivisceral transplant recipients	10
A rapid point‐of‐care polymerase chain reaction test in suspected viral respiratory tract infection after lung transplantation – A single‐center experience	10
Seroconversion after COVID‐19 vaccination and heart transplant recipients: Correspondence	10
Aspergillus spp. renal arteritis after kidney transplantation: A reappraisal	10
Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons	10
The ID Digital Institute: Building a digital education toolset and community	10
Donor‐derived infections: Current practice, global strategies, and future challenges	10
Cytomegalovirus reactivation and recalcitrant oral ulcers following coronavirus disease 2019 infection in a kidney transplant recipient	10
Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus‐Mismatched Adult and Pediatric Solid Organ Transplant Recipients	10
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole	10
Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease	9
Disseminated histoplasmosis with refractory thrombocytopenia in a renal transplant patient	9
	9
	9
Prevention and management of infectious and tropical diseases in kidney transplant recipients residing in European outermost and overseas territories	9
Impact of human leukocyte antigen compatibility on outcomes of living donor liver transplantation: Experience from a tertiary care center	9
Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study	9
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches	9
Previous use of statins does not improve the outcome of bloodstream infection after kidney transplantation	9
	9
Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis	9
A case of severe COVID‐19 despite full vaccination with mRNA‐1273 SARS‐CoV‐2 vaccine (Moderna) in a kidney transplant recipient	9
Revised nucleic acid test window periods: Applications and limitations in organ donation practice	9
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center	9
Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients	9
Impact of Bebtelovimab Treatment Timing on COVID‐19 Outcomes in Ambulatory Solid Organ Transplant Recipients	9
The intricate interplay of immunosuppression and outcomes following Gram‐negative bloodstream infection in solid organ transplantation	8
Nontuberculous mycobacterial infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation	8
Longitudinal impact of COVID‐19 on lung function in lung transplant recipients: Time to stop worrying?	8
Donor‐derived fulminant herpes simplex virus hepatitis after liver transplantation: Two cases and review of literature	8
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?	8
Road map to success: Advice for transplant infectious diseases job interviews, negotiation, and early career development	8
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipients	8
Breakthrough SARS‐CoV‐2 infections among recipients of tixagevimab‐cilgavimab prophylaxis: A citywide real‐world effectiveness study	8
Disseminated histoplasmosis with central nervous system involvement in a kidney transplant recipient	8
Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource‐Limited Settings	8
Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection	8
When a fungal infection is worse than a leukemia diagnosis	8
Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk?	8
Disseminated Mycobacterium abscessus secondary to adult onset immunodeficiency syndrome due to anti‐interferon gamma autoantibodies	8
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients	7
A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy	7
Cytomegalovirus related hospitalization costs among hematopoietic stem cell and solid organ transplant recipients treated with maribavir versus investigator‐assigned therapy: A US‐based study	7
Duration of antibiotics in kidney transplant recipients with pyelonephritis: Current practice, research gaps, and future research	7
Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report	7
Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients	7
Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients	7
Post‐transplant lymphoproliferative disorder in pediatric liver transplant recipients: Experience from a South African transplant center	7
Favorable outcomes of COVID‐19 in vaccinated hematopoietic stem cell transplant recipients: A single‐center experience	7
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023	7
Social Media Savvy, It's More Than Just the #Hashtags: How the Use of Social Media in Transplant Infectious Diseases Can Impact the Field and Patients	7
Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches	7
Microsporidiosis after liver transplantation: A French nationwide retrospective study	7
Hemophagocytic syndrome triggered by donor‐transmitted toxoplasmosis as a complication in same‐donor recipients of renal transplantation: Case report and review of the literature	7
The effectiveness and safety of low dose trimethoprim‐sulfamethoxazole for the treatment of pneumocystis pneumonia: A systematic review and meta‐analysis	7
Comment on: mRNA SARS‐CoV‐2 vaccination in patients after allogeneic hematopoietic cell transplantation	7
Hepatic granulomas in a pediatric liver transplant recipient	7
“They paged me what?”: A transplant infectious disease guide to donor calls	7
Cell‐free next‐generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study	7
	7
	7
Can Quantitative Polymerase Chain Reaction in Tissue Improve Cytomegalovirus Management? Balancing Diagnostic Sensitivity and the Risk of Overtreatment	7
Minocycline‐induced hyperpigmentation in a patient on long‐term Nocardia suppressive treatment	7
Majocchi's granuloma in a patient with GATA2 haploinsufficiency undergoing hematopoietic stem cell transplantation	7
Infection evaluation in the early period after liver transplantation: A single‐center exploration	7
Delayed diagnosis and treatment of secondary syphilis in pancreas–kidney transplant recipient: Need for increased awareness of sexually transmitted infections in solid organ transplantation	7
Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients	7
Short‐course antibiotic treatment for Gram‐negative bloodstream infection in neutropenic cancer patients: Less is more	7
Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis	7
Re: Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis against Multidrug‐Resistant Bacteria	6
Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee	6
Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants	6
Crusted Scabies with Facial Involvement in a Patient Following Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report	6
	6
Recurrent Outbreak of Carbapenem‐Resistant IMP‐1‐Producing Pseudomonas aeruginosa in Kidney Transplant Recipients: The Impact of Prolonged Patient Colonization	6
Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis	6

Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation	6
Minding the gap: How transplant infectious disease can help close the organ donation gap	6
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non‐renal solid organ transplant recipients?	6
Donor blood cultures and outcomes after lung transplantation: a single‐center report	6
	6
Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy	6
Bacterial genotype and clinical outcomes in solid organ transplant recipients with Staphylococcus aureus bacteremia	6
	6
Risk factors and outcomes of BK viremia among deceased donor kidney transplant recipients based on donor characteristics	6
Impact of high MELD scores on CMV viremia following liver transplantation	6
Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA	6
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual	6
Infections in patients with primary immunodeficiencies: Insight into infections in secondary immunodeficiency and transplantation	6
Daptomycin‐associated pulmonary toxicity sans eosinophilia in a hematopoietic cell transplant recipient with profound leukopenia	6
Impact of COVID‐19 on abdominal organ transplantation: A bibliometric analysis	6
	6
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre‐emptive monitoring in the era of letermovir	6
Organ vigilance in the Middle East: Challenges and prospects	6
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept	6
Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10‐year national cross‐sectional study	6
Antimicrobial stewardship for organ donors: Importance, current practice, and challenges	6
Cefiderocol utilization in lung transplant recipients at a single center	6
Letermovir for pre‐emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation	6
Biofire pneumonia panel in lung donors: faster detection but limited pathogens	6
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances	5
Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?	5
Hemorrhage Incognito	5
Beta‐lactam allergies, surgical site infections, and prophylaxis in solid organ transplant recipients at a single center: A retrospective cohort study	5
The nuts and bolts of transplant infectious disease training	5
Interleukin‐18 and tumor necrosis factor‐α are elevated in solid organ transplant recipients with possible cytomegalovirus end‐organ disease	5
Potential donor characteristics and decisions made by organ procurement organization staff: Results of a discrete choice experiment	5
Issue Information	5
COVID‐19 in heart transplant recipients: Outcomes according to vaccination status	5
Use of live viral vaccines after HCT: Still a lot to learn	5
Investigation of donor‐derived Strongyloides stercoralis infection in multiple solid organ transplant recipients—California, Michigan, Ohio, 2022	5
Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center	5
Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct‐acting antiviral therapies	5
Metronidazole‐induced encephalopathy after living donor liver transplantation	5
Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation – A retrospective single‐center study	5
Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid org	5
Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies	5
Clinical characteristics of COVID‐19 in solid organ transplant recipients following COVID‐19 vaccination: A multicenter case series	5
Antimicrobial stewardship in solid organ transplant—Opportunities in the National Health Service	5
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey	5
Hypercalcemia associated with Pneumocystis jirovecii pneumonia in lung transplant recipients: Two case reports	5
Pseudomonal blepharoconjunctivitis causing neutropenic sepsis after allogeneic hematopoietic cell transplantation	5
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch	5
A case report of successful kidney transplantation from a deceased donor with terminal COVID‐19‐related lung damage: Ongoing dilemma between discarding and accepting organs in COVID‐19 era!	5
Critical Insights: Severe Outcomes of Pneumocystis Pneumonia: A 10‐year Retrospective Cohort Study	5
A Scoping Review of Arthropod‐Borne Flavivirus Infections in Solid Organ Transplant Recipients	5
Issue Information	5
Addressing the Rising Burden of Carbapenemase‐Producing Enterobacterales in Liver Transplant Recipients: A Call for Enhanced Surveillance and Prevention Strategies	5
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis	5
Blastomycosis in solid organ transplant recipients—A retrospective series from southeastern Wisconsin	5
Moving xenotransplantation from bench to bedside: Managing infectious risk	5
Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients	5
Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review	5
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients – A retrospective matched cohort study	5
	5
Current state of antimicrobial stewardship and organ transplantation in Saudi Arabia	5
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria	5
Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high‐risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves	5
Issue Information	5
Issue Information	5
	5
Comment on “Re‐infection with SARS‐CoV‐2 in solid‐organ transplant recipients”	4
Antimicrobial stewardship in solid organ transplantation: Perspective from a Veterans Affairs Medical Center	4
A multicenter prospective study to define the natural history of BK viral infections in kidney transplantation	4
Aspergillus versicolor Meningitis in a Patient With Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation	4
Infections are No Holiday	4
Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates	4
Use of anti‐CMV immunoglobulins in lung transplant recipients: The French experience	4
Antibiotic allergy labels in immunocompromised populations	4
Case report: Ganoderma weberianum invasive fungal disease (IFD) during allogeneic hematopoietic stem cell transplantation (HSCT)	4
	4
Donor‐derived strongyloidiasis: The beginning of the end?	4
BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy	4
Response to Letters regarding “Re‐infection with SARS‐CoV‐2 in solid‐organ transplant (SOT) recipients: Incidence density and convalescent immunity prior to re‐infection”	4
Infections in the first year after heart transplantation in a Latin American country	4
Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients	4
Favorable experience of transplant strategy including liver grafts from COVID‐19 donors: One‐year follow‐up results	4
Outcomes of transplant recipients with pretransplant Nocardia colonization or infection	4
	4
	4
Splenic abscess caused by Toxocara spp. in a lung transplant recipient, Marseille, France	4
Auditing tools for antimicrobial prescribing in solid organ transplant recipients: The why, the how, and an assessment of current options	4
Risk of tuberculosis among renal transplant recipients receiving rituximab therapy	4
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center	4
Unexpectedly long persistence of anti‐SARS‐CoV‐2 spike monoclonal antibodies tixagevimab and cilgavimab in immunocompromised patients	4
Risk and benefits of expanded donor screening: A viewpoint from Germany	4
Efficacy of hope: Analysis of organ quality and availability among deceased HIV‐positive donors	4
Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS‐CoV‐2 infection: Correspondence	4
Central nervous system infection with Hantavirus in a solid organ transplant patient	4
Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression	4
Transplantation programs facing lack of empirical evidence on SARS‐CoV‐2 vaccination: A society recommendation consensus update	4